Nutritional Status of Gaucher Disease Patients
Evaluation of the Nutritional Status of Gaucher's Disease Patients
1 other identifier
observational
84
0 countries
N/A
Brief Summary
This cross-sectional study aims to evaluate the nutritional status of patients with Gaucher disease attending Assiut University Children's Hospital using anthropometric measurements and body composition analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2026
CompletedStudy Start
First participant enrolled
September 26, 2026
CompletedFirst Posted
Study publicly available on registry
September 28, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 26, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 25, 2028
September 28, 2026
September 1, 2026
1 year
September 22, 2026
September 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of underweight
Proportion of patients with weight-for-age below -2 standard deviations according to WHO growth charts.
Baseline
Secondary Outcomes (5)
Prevalence of stunting
Baseline
Mean body mass index
Baseline
Mean mid-arm circumference
Baseline
Mean fat mass percentage
Baseline
Mean lean body mass
Baseline
Study Arms (1)
Single cohort: Gaucher Disease Patients
Patients with confirmed Gaucher disease (types 1, 2, and 3) who will undergo nutritional assessment including anthropometry and body composition analysis.
Eligibility Criteria
Patients with confirmed Gaucher disease attending Assiut University Children's Hospital for follow-up visits.
You may qualify if:
- Confirmed diagnosis of Gaucher disease (type 1, 2, or 3)
- Undergoing a follow-up visit at Assiut University Children's Hospital
- Written informed consent from caregivers
You may not qualify if:
- Other autosomal recessive lysosomal storage diseases
- Not undergoing a follow-up visit at Assiut University Children's Hospital
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mostafa M Embaby, prof
Pediatrics Department, Assiut University Hospitals
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident Physician, Department of Pediatrics
Study Record Dates
First Submitted
September 22, 2026
First Posted
September 28, 2026
Study Start
September 26, 2026
Primary Completion (Estimated)
September 26, 2027
Study Completion (Estimated)
February 25, 2028
Last Updated
September 28, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share